Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Improved Glycemic Control in Patients With Type 2 Diabetes”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Not applicableUnknownNCT05266625
What this trial is testing

Digital Therapeutic Based Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Better Therapeutics 500
Large-scale testing (Phase 3)UnknownNCT03970031
What this trial is testing

MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH

Who this might be right for
Type2 DiabetesNASH - Nonalcoholic SteatohepatitisNonalcoholic Steatohepatitis+1 more
Cirius Therapeutics, Inc. 1,800
Not applicableStudy completedNCT03102424
What this trial is testing

Transcutaneous Electrical Nerve Stimulator to Improve Blood Glucose Control in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Taiwan Resonant Waves Research Corporation 160
Not applicableStudy completedNCT01460446
What this trial is testing

ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)?

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Hoffmann-La Roche 218
Early research (Phase 1)UnknownNCT05151705
What this trial is testing

A Trial of HR17031 Injection With Hepatic Insufficiency

Who this might be right for
Improved Glycemic Control in Patients With Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 24
Post-approval studies (Phase 4)UnknownNCT02517242
What this trial is testing

Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic Control

Who this might be right for
Diabetes
Hospital de Clinicas de Porto Alegre 112
Very early researchUnknownNCT01671189
What this trial is testing

Automated SMS-Based Appointment Validation Tool

Who this might be right for
Diabetes Mellitus Type 2Adult-onset Diabetes
Medic Mobile 300
Not applicableNot Yet RecruitingNCT07165730
What this trial is testing

Virtual Health Coaching With Artificial Intelligence for Glycemic Control in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Hasanuddin University 206
Not applicableEnded earlyNCT04158921
What this trial is testing

Control:Diabetes Pilot Study I

Who this might be right for
Insulin Treated Type 2 Diabetes MellitusDiabetes Mellitus, Type 1
Brigham and Women's Hospital 55
Testing effectiveness (Phase 2)Ended earlyNCT01987674
What this trial is testing

Pre-meal Protein Drink Improve Glycemic Regulation

Who this might be right for
Type 2 Diabetes Mellitus
Lund University 35
Large-scale testing (Phase 3)Study completedNCT00348374
What this trial is testing

Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Pfizer 191
Not applicableStudy completedNCT05527847
What this trial is testing

Peers EXCEL Trial to Improve Glycemic Control

Who this might be right for
Type 2 Diabetes
University of Wisconsin, Madison 14
Not applicableLooking for participantsNCT06814184
What this trial is testing

Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy

Who this might be right for
Type 2 Diabetes
Rutgers, The State University of New Jersey 60
Large-scale testing (Phase 3)Study completedNCT00545584
What this trial is testing

Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Merck Sharp & Dohme LLC 1,512
Post-approval studies (Phase 4)Study completedNCT04288778
What this trial is testing

Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes

Who this might be right for
Diabetes Mellitus
Johnson & Johnson Private Limited 276
Not applicableStudy completedNCT05491252
What this trial is testing

Controlled Trial of Patient-Centered Self-Management Intervention in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Shifa Tameer-e-Millat University 612
Testing effectiveness (Phase 2)Ended earlyNCT05368402
What this trial is testing

Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.

Who this might be right for
Type 1 Diabetes
Dompé Farmaceutici S.p.A 3
Early research (Phase 1)Study completedNCT05292495
What this trial is testing

A Trial of HR17031 Injection With Renal Insufficiency

Who this might be right for
Improved Glycemic Control in Patients With Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 24